Publications: group B Streptococcus

2000 to Present:

 Top of Page

 1995-1999:

  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1999.
  • Centers for Disease Control and Prevention. Laboratory practices for prenatal group B streptococcal screening and reporting. MMWR Morb Mortal Wkly Rep. 1999;48(20):426-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1998.
  • Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease – United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47(32):665-70.
  • Harrison LH, Elliot JA, Libonati JP, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis. 1998;177:998-1002.
  • Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. J Infect Dis. 1998;178:569-72.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group B Streptococcus, 1997.
  • Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease — United States, 1993-1995. MMWR Morb Mortal Wkly Rep. 1997;46(21):473-7.
  • Rosenstein NE , Schuchat A, and the Neonatal Group B Streptococcal Disease Study Group. Opportunities for prevention of perinatal group B streptococcal disease: a multi-state surveillance analysis. Obstet Gynecol. 1997;90:901-6.
  • Whitney C, Plikaytis BD, Gozansky W, Schuchat A, Neonatal group B streptococcal disease study group. Prevention practices for perinatal group B streptococcal disease: a multistate surveillance analysis. Obstet Gynecol. 1997;89:28-32.
  • Blumberg HM, Stephens DS, Modansky M, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996;173:365-73.
  • Jackson L, Farley M, Schuchat A. Adult group B streptococcal disease. Ann Int Med. 1996;125;152-3.
  • Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep. 1996;45 (RR-7):1-24.
  • Farley MM. Group B streptococcal infection in older patients: Spectrum of disease and management strategies. Drugs and Aging. 1995;6:293-300.
  • Harrison LH, Ali A, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Intern Med. 1995;123:421-7.
  • Jackson L, Hilsdon R, Farley M, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123:415-20.

 Top of Page

1992-1994:

  • Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13:623-9.
  • Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med. 1993;328:1807-11.
  • Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis. JAMA. 1993;270:1442-8.
  • Zangwill KM, Schuchat A, Wenger JD, and the Group B Streptococcal Disease Study Group. Group B streptococcal disease in the United States: Report from a multistate active surveillance system. MMWR Morb Mortal Wkly Rep. 1992;41[No. SS-6]:25-32.

 Top of Page